TrialPloS one2015

A Phase 1 Randomized, Open Label, Rectal Safety, Acceptability, Pharmacokinetic, and Pharmacodynamic Study of Three Formulations of Tenofovir 1% Gel (the CHARM-01 Study).

Ian Mcgowan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.